Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
Eliem Therapeutics, Inc (ELYM)
Company Research
Source: GlobeNewswire
SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel 2024 Virtual Immunology and Inflammation Summit being held September 17-18, 2024. Stifel 2024 Virtual Immunology and Inflammation SummitDate: Wednesday, September 18, 2024Format: 1x1 meetings About Eliem Therapeutics, Inc.Eliem Therapeutics is focused on developing therapeutics for autoimmune-driven inflammatory diseases, including advancing budoprutug, an anti-CD19 antibody designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia and membranous nephropathy. For more information, please visit https://eliemtx.com/. InvestorsChris Brinzey ICR Westwickechris.brinzey@westwicke.com339-970-2843 Source: Eliem Therapeutics, Inc.
Show less
Read more
Impact Snapshot
Event Time:
ELYM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELYM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELYM alerts
High impacting Eliem Therapeutics, Inc news events
Weekly update
A roundup of the hottest topics
ELYM
News
- Eliem Therapeutics Announces Additions to its Leadership TeamGlobeNewswire
- Eliem Therapeutics Reports Second Quarter Financial Results [Yahoo! Finance]Yahoo! Finance
- Eliem Therapeutics Reports Second Quarter Financial ResultsGlobeNewswire
- BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- VectorY Appoints Seasoned Biotech Leader Adam Rosenberg as Chair of the Board [Yahoo! Finance]Yahoo! Finance
ELYM
Sec Filings
- 9/20/24 - Form 4
- 8/27/24 - Form 8-K
- 8/26/24 - Form 4
- ELYM's page on the SEC website